Biliary Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-08-05
EMA Authorised: Iqirvo (Elafibranor) — Ipsen Pharma
Elafibranor (Iqirvo) by Ipsen Pharma has been authorised with conditional approval as an orphan medicine for liver cirrhosis and biliary dis…